Your browser doesn't support javascript.
Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Rizk, John G; Lavie, Carl J; Gupta, Ajay.
  • Rizk JG; Arizona State University, Edson College, Phoenix, AZ, USA.
  • Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA, USA.
  • Gupta A; Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, School of Medicine, Irvine, CA, USA.
Expert Opin Investig Drugs ; 30(8): 785-788, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1287916
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Aspirin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Expert Opin Investig Drugs Journal subject: Drug Therapy Year: 2021 Document Type: Article Affiliation country: 13543784.2021.1950687

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Aspirin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Expert Opin Investig Drugs Journal subject: Drug Therapy Year: 2021 Document Type: Article Affiliation country: 13543784.2021.1950687